Cargando…
Comparative study of Dapagliflozin versus Glimepiride effect on insulin regulated aminopeptidase (IRAP) and interleukin-34 (IL-34) in patient with type 2 diabetes mellitus
Type 2 diabetes mellitus (T2DM) is one of the most common diseases, that managed by several medications such as Glimepiride and Dapagliflozin. This study aims to compare the effects of Dapagliflozin versus Glimepiride on glycemic control, insulin resistance, and biomarkers as (extracellular domain o...
Autores principales: | Zekry, Rania, Omran, Gamal A., El-Gharbawy, Nashwa M., Werida, Rehab H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113266/ https://www.ncbi.nlm.nih.gov/pubmed/37072577 http://dx.doi.org/10.1038/s41598-023-33417-3 |
Ejemplares similares
-
Author Correction: Comparative study of Dapagliflozin versus Glimepiride effect on insulin regulated aminopeptidase (IRAP) and interleukin-34 (IL-34) in patient with type 2 diabetes mellitus
por: Zekry, Rania, et al.
Publicado: (2023) -
Inhibition of Insulin-Regulated Aminopeptidase (IRAP) by Arylsulfonamides
por: Borhade, Sanjay R, et al.
Publicado: (2014) -
Circulating IL-6, clusterin and irisin in obese subjects with different grades of obesity: association with insulin resistance and sexual dimorphism
por: Werida, Rehab H., et al.
Publicado: (2021) -
IRAP Inhibitors: M1-Aminopeptidase Family Inspiration
por: Barlow, Nicholas, et al.
Publicado: (2020) -
The Discovery of Insulin-Regulated Aminopeptidase (IRAP) Inhibitors: A Literature Review
por: Georgiadis, Dimitris, et al.
Publicado: (2020)